AACC uses cookies to ensure the best website experience. Continuing without changing cookie settings assumes you consent to our use of cookies on this device. You can change these settings at any time, but that may impair functionality on our websites. Review our cookie and privacy policy

Danielle Vance

Dr Danielle Vance obtained a BSci (Hons) in Medicinal Chemistry and a PhD in Organic Chemistry from Queen’s University Belfast. Danielle joined Randox in 2011 as a Research Scientist working on the development of clinical immunoassays for the Evidence platforms. Danielle manages a team of scientists within the R&D Clinical immunoassay development department who are responsible for the development of new clinical multiplexed assays for improved sensitivity and detection of cardiac targets (Troponin I, H-FABP and CKMB), thyroid targets (FT3, FT4, TSH, TT3, TT4), and other clinically relevant arrays such as the Endocrine array, Anaemia array and the Metabolic Syndrome array.


Scientific Shorts